Three early-career researchers were recognized for the scientific merit of their abstracts and their valuable contributions to the field of immuno-oncology at the 2020 ASCO-SITC Immuno-Oncology Symposium. Conquer Cancer, the ASCO Foundation, recognized Hitomi Jo, MD, Linxiaoxi Ma, and Yara Abdou, MD.

Didier Verhoeven, MD, PhD, Cary S. Kaufman, MD, Robert E. Mansel, MD, and Sabine Siesling, PhD, served as editors of Breast Cancer: Global Quality Care, recently published by Oxford University Press. 125 experts, including numerous ASCO members, from 25 countries served as contributors to the book.

Translational Research in Oncology appointed Peter Fasching, MD, to their Board of Directors.

Mehra Golshan, MD, MBA, FACS, has been appointed the inaugural deputy chief medical officer for surgical services at Smilow Cancer Hospital and Yale Cancer Center, professor of surgery at Yale School of Medicine, and interim director of the Breast Center at Smilow Cancer Hospital.

Robert L. Coleman, MD, FACOG, FACS, FASCO, has been named chief scientific officer for the US Oncology Network.

Eric A. Brown, MD, FACS, has joined the staff at Karmanos Cancer Institute as co-leader of the Breast Cancer Multidisciplinary Team.

City of Hope welcomed Stanley Hamilton, MD, and Alexey Danilov, MD, PhD, to the National Medical Center in Duarte, California. Dr. Hamilton is serving as chair of the Department of Pathology, and Dr. Danilov is bringing his independently funded lab to City of Hope’s Toni Stephenson Lymphoma Center, where he is associate director.

The Yale Cancer Center has announced the appointment of Amer Zeidan, MBBS, as director of the Hematology Early Therapeutics Program.

Jeff Patton, MD, has been named chief executive officer of OneOncology.

The ASCO Post contributed reporting.